Astellas Pharma Net Income 2012-2019 | ALPMY

Astellas Pharma annual/quarterly net income history and growth rate from 2012 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Astellas Pharma net income for the quarter ending June 30, 2019 was $0.533B, a 14.04% decline year-over-year.
  • Astellas Pharma net income for the twelve months ending June 30, 2019 was $1.892B, a 1.65% increase year-over-year.
  • Astellas Pharma annual net income for 2018 was $1.554B, a 20.43% decline from 2017.
  • Astellas Pharma annual net income for 2017 was $1.953B, a 21.49% increase from 2016.
  • Astellas Pharma annual net income for 2016 was $1.608B, a 30.03% increase from 2015.
Astellas Pharma Annual Net Income
(Millions of US $)
2018 $1,554
2017 $1,953
2016 $1,608
2015 $1,236
2014 $882
2013 $881
2012 $954
2011 $836
2010 $1,319
2009 $1,761
2008 $1,714
2007 $1,091
2006 $942
Astellas Pharma Quarterly Net Income
(Millions of US $)
Q1 2019 $533
Q1 2018 $502
Q1 2017 $382
Q2 2016 $475
Q1 2016 $620
Q4 2016 $259
Q3 2015 $505
Q2 2015 $478
Q1 2015 $366
Q4 2015 $163
Q3 2014 $394
Q2 2014 $327
Q1 2014 $351
Q4 2014
Q3 2013
Q2 2013
Q1 2013 $223
Q4 2013
Q3 2012
Q2 2012
Q1 2012 $444
Q4 2012
Q3 2011
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $31.345B $11.834B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.496B 10.03
Zoetis (ZTS) United States $56.165B 33.60
Eisai (ESALY) Japan $18.870B 36.39
Merck (MKGAF) Germany $15.276B 20.85
Grifols, S.A (GRFS) Spain $14.913B 19.03
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.411B 491.52
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.244B 16.70
Jazz Pharmaceuticals (JAZZ) Ireland $7.843B 10.02
Sage Therapeutics (SAGE) United States $7.582B 0.00
Catalent (CTLT) United States $7.377B 30.01
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.134B 18.45
Arrowhead Pharmaceuticals (ARWR) United States $4.498B 103.13
United Therapeutics (UTHR) United States $3.968B 0.00
Nektar Therapeutics (NKTR) United States $3.457B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.363B 12.29
FibroGen (FGEN) United States $3.227B 94.85
Evotec AG (EVTCY) Germany $3.081B 50.42
PTC Therapeutics (PTCT) United States $2.693B 0.00
Portola Pharmaceuticals (PTLA) United States $2.117B 0.00
Xencor (XNCR) United States $2.041B 62.03
Tilray (TLRY) Canada $1.998B 0.00
Zogenix (ZGNX) United States $1.998B 0.00
Heron Therapeutics (HRTX) United States $1.943B 0.00
Corcept Therapeutics (CORT) United States $1.879B 22.83
Ironwood Pharmaceuticals (IRWD) United States $1.800B 57.40
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.560B 16.65
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.232B 20.33
Radius Health (RDUS) United States $1.108B 0.00
Endo (ENDP) Ireland $1.027B 1.89
Theravance Biopharma (TBPH) Cayman Islands $1.013B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
ArQule (ARQL) United States $0.951B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.938B 0.00
Aerie Pharmaceuticals (AERI) United States $0.877B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.823B 5.61
Organogenesis Holdings (ORGO) United States $0.758B 0.00
TherapeuticsMD (TXMD) United States $0.743B 0.00
Flexion Therapeutics (FLXN) United States $0.614B 0.00
Collegium Pharmaceutical (COLL) United States $0.607B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ChemoCentryx (CCXI) United States $0.513B 0.00
ImmunoGen (IMGN) United States $0.495B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.492B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.459B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.458B 55.50
Crinetics Pharmaceuticals (CRNX) United States $0.450B 0.00
OptiNose (OPTN) United States $0.433B 0.00
Dermira (DERM) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.402B 9.19
Akebia Therapeutics (AKBA) United States $0.400B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.392B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.389B 16.78
Recro Pharma (REPH) United States $0.389B 0.00
Indivior (INVVY) United States $0.387B 1.40
Ardelyx (ARDX) United States $0.386B 0.00
DURECT (DRRX) United States $0.373B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.369B 4.29
Harpoon Therapeutics (HARP) United States $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.288B 0.00
GlycoMimetics (GLYC) United States $0.270B 0.00
Molecular Templates (MTEM) United States $0.268B 0.00
Rafael Holdings (RFL) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.222B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.209B 0.00
KalVista Pharmaceuticals (KALV) United States $0.197B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.37
Calithera Biosciences (CALA) United States $0.188B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
Jounce Therapeutics (JNCE) United States $0.174B 2.33
Matinas Biopharma Holdings (MTNB) United States $0.169B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.163B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Aquestive Therapeutics (AQST) United States $0.150B 0.00
Redhill Biopharma (RDHL) Israel $0.137B 0.00
MEI Pharma (MEIP) United States $0.135B 0.00
Ocular Therapeutix (OCUL) United States $0.135B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.134B 0.00
CV Sciences (CVSI) United States $0.134B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.131B 0.00
IMV INC (IMV) Canada $0.126B 0.00
CannTrust Holdings (CTST) Canada $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.092B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.076B 0.00
Otonomy (OTIC) United States $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 22.05
Generex Biotechnology (GNBT) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.062B 0.00
Natural Alternatives (NAII) United States $0.061B 15.18
Genocea Biosciences (GNCA) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.053B 0.00
Novan (NOVN) United States $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
Capnia (SLNO) United States $0.049B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.031B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.031B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Mast Therapeutics (SVRA) United States $0.030B 0.00
Biomerica (BMRA) United States $0.029B 0.00
IsoRay (ISR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00